Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%
Ph early_phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
50.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting250%
terminated125%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

The Effect of Lavender Inhalation on Anxiety, Sleep, and Blood Pressure

NCT07192783
recruitingnot_applicable

The Effect of Lavender Essential Oil for Delirium in Elderly Intensive Care Unit Patients: Study Protocol

NCT06100029
terminatedearly_phase_1

Aromatherapy for Chemotherapy-induced Symptoms

NCT02670941
completednot_applicable

Lavender During Intrauterine Insemination

NCT03461055

Clinical Trials (4)

Showing 4 of 4 trials
NCT07192783Not Applicable

The Effect of Lavender Inhalation on Anxiety, Sleep, and Blood Pressure

Recruiting
NCT06100029Not Applicable

The Effect of Lavender Essential Oil for Delirium in Elderly Intensive Care Unit Patients: Study Protocol

Recruiting
NCT02670941Early Phase 1

Aromatherapy for Chemotherapy-induced Symptoms

Terminated
NCT03461055Not Applicable

Lavender During Intrauterine Insemination

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4